The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma
Authors:
Open Access
- 11 December 2020
- journal article
- research article
- Published by Wiley in Analytical Cellular Pathology
- Vol. 2020, 1-17
Abstract
Background. Esophageal squamous cell carcinoma was treated by operation and chemoradiotherapy. However, the prognosis of most patients is poor after treatment, and most studies have shown that FGF2 and its receptor (FGFR) are involved in the development of various malignant tumors. FGF2 plays an important role in tumor progression and malignancy. In this study, the immunohistochemistry of FGF2, FGFR3, and FGFBP1 was used to further verify the expression of the three proteins in 172 patients with esophageal squamous cell carcinoma (ESCC) who had not received preoperative chemoradiotherapy and its effect on the prognosis of ESCC. Methods. (1) test was used to analyze the relationship between proteins and clinicopathological parameters. Survival analysis was used to investigate the effect of three proteins on prognosis. (2) Paired sample -test was used to analyze the mRNA expression of the three proteins in fresh ESCC tissues and adjacent normal tissues. Results. FGF2 was correlated with tumor size ( ), gender ( ), and lymph metastasis ( ) in ESCC tissues. The high expression of FGFR3 was associated with tumor differentiation ( and ), lymph node metastasis ( and ), and race ( and ). The high expression of FGFBP1 was significantly associated with the degree of tumor differentiation ( ), age ( ), and lymph node metastasis ( ) of ESCC patients. The expression of FGF2, FGFR3, and FGFBP1-mRNA in ESCC tissues was significantly higher than that in adjacent tissues ( , , and <svg xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/2000/svg" width="18.973pt" style="vertical-align:-3.42938pt" id="M17" height="11.7782pt" version="1.1"...Keywords
Funding Information
- State Key Laboratory of Pathogenesis and Prevention of High Incidence in Central Asia (SKL-HIDCA-2020-4, 81860422)
- National Natural Science Foundation of China (SKL-HIDCA-2020-4, 81860422)
This publication has 50 references indexed in Scilit:
- Impact of Fibroblast Growth Factor-Binding Protein–1 Expression on Angiogenesis and Wound HealingThe American Journal of Pathology, 2011
- Current standard and trends in oesophageal cancerEuropean Journal of Cancer, 2011
- Roles of Fibroblast Growth Factor Receptors in CarcinogenesisMolecular Cancer Research, 2010
- Fibroblast growth factors: from molecular evolution to roles in development, metabolism and diseaseThe Journal of Biochemistry, 2010
- Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migrationBritish Journal of Cancer, 2010
- Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in miceJournal of Clinical Investigation, 2009
- The FGF family: biology, pathophysiology and therapyNature Reviews Drug Discovery, 2009
- The Angiogenic Switch Molecule, Secreted FGF-Binding Protein, an Indicator of Early Stages of Pancreatic and Colorectal AdenocarcinomaSeminars in Oncology, 2006
- Basic fibroblast growth factor (FGF‐2): The high molecular weight forms come of ageJournal of Cellular Biochemistry, 2006
- Receptor Specificity of the Fibroblast Growth Factor FamilyJournal of Biological Chemistry, 2006